日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CYB561 is a potential therapeutic target for breast cancer and is associated with immune cell infiltration.

CYB561 是乳腺癌的潜在治疗靶点,与免疫细胞浸润有关

Zhuo Jian, Zhao Yanchun, Hao Ruiying, Li He, Zheng Zilin, Dai Luxian, Sheng Ankang, Yao Hanyu, Tang Yubao, Wang Rao, Yang Xiaohong, Liu Weiguang

RAB10 promotes breast cancer proliferation migration and invasion predicting a poor prognosis for breast cancer

RAB10促进乳腺癌细胞增殖、迁移和侵袭,预示乳腺癌预后不良

Zhuo, Jian; Han, Jianjun; Zhao, Yanchun; Hao, Ruiying; Shen, Chong; Li, He; Dai, Luxian; Sheng, Ankang; Yao, Hanyu; Yang, Xiaohong; Liu, Weiguang